Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist  Ronald L. Schnaar, PhD  Journal of.

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Allergen immunotherapy: A practice parameter third update
Fatty acids, inflammation, and asthma
Laurent L'homme, PhD, David Dombrowicz, PhD 
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Role of platelets in allergic airway inflammation
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Glycans and glycan-specific IgE in clinical and molecular allergology: Sensitization, diagnostics, and clinical symptoms  Arne Homann, PhD, Gabriele Schramm,
Fatty acids, inflammation, and asthma
Reassessing the role of hyaluronidase in yellow jacket venom allergy
Zuhair K. Ballas, MD  Journal of Allergy and Clinical Immunology 
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
The National Biome Initiative: An allergy perspective
Nonadherence to Asthma Treatment: Getting Unstuck
Update on epigenetics in allergic disease
Etiology of asthma exacerbations
Epithelium: At the interface of innate and adaptive immune responses
The future of allergy/immunology: Promising young investigators
Practice Notes from the AAAAI
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Biologics and biomarkers for asthma, urticaria, and nasal polyposis
Ricardo U. Sorensen, MD, Luke A. Wall, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
News & Notes Journal of Allergy and Clinical Immunology
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
“Accentuate the negative, eliminate the positive”: Engineering allergy therapeutics to block allergic reactivity through negative signaling  Andrew Saxon,
What is an “eosinophilic phenotype” of asthma?
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Cephalosporin Side Chain Cross-reactivity
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Cockroach allergens: Coping with challenging complexity
Autophagy: Nobel Prize 2016 and allergy and asthma research
Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy.
News & Notes Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Geographic variability in childhood asthma prevalence in Chicago
Clinical consequences of defects in B-cell development
Chemokines and their receptors in allergic disease
Cagri Yildirim-Toruner, MD, Betty Diamond, MD 
One step forward, 2 steps back: The enigma of preschool wheeze
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Practice Notes from the AAAI
Innate immune responses to infection
Measles and immunomodulation
Stefan Schülke, PhD, Stefan Vieths, PhD 
Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation  Takumi Kiwamoto,
Macrolide antibiotics and asthma treatment
Cure of HIV infection: Is the long wait over?
Natural killer cell biology: An update and future directions
Immune pathomechanism of drug hypersensitivity reactions
Asthma: The past, future, environment, and costs
Genetic regulation of IgE responses: Achilles and the tortoise
Environmental factors and eosinophilic esophagitis
News & Notes Journal of Allergy and Clinical Immunology
Advances in pediatric asthma in 2007
Safety and efficacy of repeated monthly carboplatin desensitization
Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation  Takumi Kiwamoto,
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Chitinases and chitinase-like proteins in TH2 inflammation and asthma
Presentation transcript:

Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist  Ronald L. Schnaar, PhD  Journal of Allergy and Clinical Immunology  Volume 135, Issue 3, Pages 609-615 (March 2015) DOI: 10.1016/j.jaci.2014.10.057 Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Cell-surface glycans. All mammalian cells are endowed with a dense and diverse surface coat of glycans comprised of glycoproteins, proteoglycans, and glycolipids. They are built primarily from just 9 different monosaccharide building blocks, each of which is a 6-membered ring with distinct structural substituents. A color-coded symbol nomenclature for these (see the key in the illustration) has been agreed upon by the field.10 N-linked glycans are attached to protein asparagine residues and are invariably branched structures that display varied termini. O-linked glycans are attached to protein serine or threonine residues and typically consist of shorter branched or unbranched structures. Proteoglycans are also attached to protein serine or threonine residues but are notable for their long disaccharide repeats, most of which are highly charged because of the abundance of sugar acids and sulfates. Mammalian glycolipids primarily consist of glycans attached to a ceramide lipid moiety. Together, these glycans comprise the glycome of each cell, providing it with the diverse surface structures required for that cell's functions. Journal of Allergy and Clinical Immunology 2015 135, 609-615DOI: (10.1016/j.jaci.2014.10.057) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Representative roles of glycans and GBPs in immune regulation. Left panel, Galectin-3 cross-links TCRs through their N-linked glycans to regulate immune activation.24 APC, Antigen-presenting cell. Center panel, E- and P-selectins engage glycans on the surfaces of passing leukocytes to mediate the initial (tethering) step of inflammation. PSGL-1, P-selectin glycoprotein ligand 1.25 Right panel, Siglec-1 (sialoadhesin) captures sialylated pathogens for clearance and antigen presentation but can be commandeered by HIV for transinfection and dissemination. GBS, Group B Streptococcus.26 Journal of Allergy and Clinical Immunology 2015 135, 609-615DOI: (10.1016/j.jaci.2014.10.057) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions